Sfoglia per Autore
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy.
2012-01-01 Milella, M; Nuzzo, C; Bria, E; Sperduti, I; Visca, P; Buttitta, Fiamma; Antoniani, B; Merola, R; Gelibter, A; Cuppone, F; D'Alicandro, V; Ceribelli, A; Rinaldi, M; Cianciulli, A; Felicioni, LARA BARBARA; Malatesta, Sara; Marchetti, Antonio; Mottolese, M; Cognetti, F.
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
2012-01-01 Schirosi, L; Nannini, N; Nicoli, D; Cavazza, A; Valli, R; Buti, S; Garagnani, L; Sartori, G; Calabrese, F; Marchetti, Antonio; Buttitta, Fiamma; Felicioni, LARA BARBARA; Migaldi, M; Rea, F; Di Chiara, F; Mengoli, Mc; Rossi, G.
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment
2014-01-01 Marchetti, Antonio; Del Grammastro, Maela; Felicioni, Lara; Malatesta, Sara; Filice, Giampaolo; Centi, Irene; De Pas, Tommaso; Santoro, Armando; Chella, Antonio; Brandes, Alba Ariela; Venturino, Paola; Cuccurullo, Franco; Crinò, Lucio; Buttitta, Fiamma
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer
2014-01-01 Gasparini, Giampietro; Buttitta, Fiamma; D'Andrea Mario, Rosario; Tumolo, Salvatore; Buonadonna, Angela; Pavese, Ida; Cordio, Stefano; DE TURSI, Michele; Mosconi, Stefania; Stumbo, Luciano; Felicioni, Lara; Marchetti, Antonio
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor
2015-01-01 Palma, J; Marchetti, A; Felicioni, L; De Pas, T; Chiari, R; Del Grammastro, M; Filice, G; Ludovini, V; Brandes, Aa; Chella, A; Malorgio, F; Guglielmi, F; De Tursi, M; Santoro, A; Crino, L; Buttitta, F
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays
2016-01-01 Marchetti, Antonio; Pace, Maria Vittoria; Di Lorito, Alessia; Canarecci, Sara; Felicioni, Lara; D'Antuono, Tommaso; Liberatore, Marcella; Filice, Giampaolo; Guetti, Luigi; Mucilli, Felice; Buttitta, Fiamma
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice
2019-01-01 Cortellini, A.; Cannita, K.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Dal Mas, A.; Calvisi, G.; Giordano, A. V.; Vicentini, V.; Vicentini, R.; Felicioni, L.; Marchetti, A.; Buttitta, F.; Russo, A.; Ficorella, C.
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: A study of the Italian NGS Network
2021-01-01 Fumagalli, C.; Guerini-Rocco, E.; Buttitta, F.; Iapicca, P.; You, W.; Mauri, M.; Felicioni, L.; Troncone, G.; Malapelle, U.; Scarpa, A.; Zamboni, G.; Calistri, D.; Barberis, M.; Marchetti, A.
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor
2023-01-01 D'Angelo, Emanuela; Espinosa, Iñigo; Felicioni, Lara; Buttitta, Fiamma; Prat, Jaime
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. | 2012 | Milella, M; Nuzzo, C; Bria, E; Sperduti, I; Visca, P; Buttitta, Fiamma; Antoniani, B; Merola, R; Gelibter, A; Cuppone, F; D'Alicandro, V; Ceribelli, A; Rinaldi, M; Cianciulli, A; Felicioni, LARA BARBARA; Malatesta, Sara; Marchetti, Antonio; Mottolese, M; Cognetti, F. | |
| Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. | 2012 | Schirosi, L; Nannini, N; Nicoli, D; Cavazza, A; Valli, R; Buti, S; Garagnani, L; Sartori, G; Calabrese, F; Marchetti, Antonio; Buttitta, Fiamma; Felicioni, LARA BARBARA; Migaldi, M; Rea, F; Di Chiara, F; Mengoli, Mc; Rossi, G. | |
| Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment | 2014 | Marchetti, Antonio; Del Grammastro, Maela; Felicioni, Lara; Malatesta, Sara; Filice, Giampaolo; Centi, Irene; De Pas, Tommaso; Santoro, Armando; Chella, Antonio; Brandes, Alba Ariela; Venturino, Paola; Cuccurullo, Franco; Crinò, Lucio; Buttitta, Fiamma | |
| Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer | 2014 | Gasparini, Giampietro; Buttitta, Fiamma; D'Andrea Mario, Rosario; Tumolo, Salvatore; Buonadonna, Angela; Pavese, Ida; Cordio, Stefano; DE TURSI, Michele; Mosconi, Stefania; Stumbo, Luciano; Felicioni, Lara; Marchetti, Antonio | |
| Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor | 2015 | Palma, J; Marchetti, A; Felicioni, L; De Pas, T; Chiari, R; Del Grammastro, M; Filice, G; Ludovini, V; Brandes, Aa; Chella, A; Malorgio, F; Guglielmi, F; De Tursi, M; Santoro, A; Crino, L; Buttitta, F | |
| Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays | 2016 | Marchetti, Antonio; Pace, Maria Vittoria; Di Lorito, Alessia; Canarecci, Sara; Felicioni, Lara; D'Antuono, Tommaso; Liberatore, Marcella; Filice, Giampaolo; Guetti, Luigi; Mucilli, Felice; Buttitta, Fiamma | |
| Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice | 2019 | Cortellini, A.; Cannita, K.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Dal Mas, A.; Calvisi, G.; Giordano, A. V.; Vicentini, V.; Vicentini, R.; Felicioni, L.; Marchetti, A.; Buttitta, F.; Russo, A.; Ficorella, C. | |
| Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: A study of the Italian NGS Network | 2021 | Fumagalli, C.; Guerini-Rocco, E.; Buttitta, F.; Iapicca, P.; You, W.; Mauri, M.; Felicioni, L.; Troncone, G.; Malapelle, U.; Scarpa, A.; Zamboni, G.; Calistri, D.; Barberis, M.; Marchetti, A. | |
| Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor | 2023 | D'Angelo, Emanuela; Espinosa, Iñigo; Felicioni, Lara; Buttitta, Fiamma; Prat, Jaime |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile